ClinicalTrials.gg
Not yet recruitingNCT07911462Updated Nov 2, 2026

Digital SSI to Reduce IWS

An interventional study of Psychoeducation and Self-compassion in Weight Bias, sponsored by Dartmouth-Hitchcock Medical Center. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-02.

Sponsored by Dartmouth-Hitchcock Medical Center · Not applicable, Interventional, and Treatment

Updated Nov 2, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
610
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this research is to evaluate a brief digital single-session intervention designed to reduce internalized weight stigma among Dartmouth Health Weight Center patients. The study will examine whether the intervention is feasible, acceptable, safe, and helpful, and will examine how patients use and engage with the intervention in routine care. What we learn may help improve future approaches to reducing weight stigma and supporting patient well-being and engagement in care.

02

Conditions studied

  • Weight Bias

Browse trials for

03

In context

Weight Prejudice

29 studies on the registry are indexed under Weight Prejudice; 7 are open to participants now.

This study's planned enrollment of 610 is above the median of 116 across 24 interventional studies indexed under Weight Prejudice.

Browse Weight Prejudice studies →

Lead sponsor

Dartmouth-Hitchcock Medical Center is the lead sponsor of 488 studies on the registry; 71 are open to participants now.

Of its 31 completed or terminated interventional studies of FDA-regulated products, 21 (68%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Sent new-patient onboarding message for Dartmouth Health Weight Center

Exclusion criteria

Exclusion Criteria:

  • \< 18 years old
  • Unwilling or unable to provide consent for participation
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Factorial assignment
Masking
Single (Participant)
Enrollment
610 participants (estimated)

Study arms

  • Active comparator
    Arm 1

    Psychoeducation only

    Behavioral: Psychoeducation

  • Experimental
    Arm 2

    Self compassion only

    Behavioral: Self-compassion

  • Experimental
    Arm 3

    Body function only

    Behavioral: Body functionality

  • Experimental
    Arm 4

    Cognitive dissonance only

    Behavioral: Cognitive Dissonance

  • Experimental
    Arm 5

    Psychoeducation + self compassion

    Behavioral: Psychoeducation · Behavioral: Self-compassion

  • Experimental
    Arm 6

    Psychoeducation + body function

    Behavioral: Psychoeducation · Behavioral: Body functionality

  • Experimental
    Arm 7

    Psychoeducation + cognitive dissonance

    Behavioral: Psychoeducation · Behavioral: Cognitive Dissonance

  • Experimental
    Arm 8

    Psychoeducation + self compassion + body function

    Behavioral: Psychoeducation · Behavioral: Self-compassion · Behavioral: Body functionality

  • Experimental
    Arm 9

    Psychoeducation + self compassion + cognitive dissonance

    Behavioral: Psychoeducation · Behavioral: Self-compassion · Behavioral: Cognitive Dissonance

  • Experimental
    Arm 10

    Psychoeducation + body function + cognitive dissonance

    Behavioral: Psychoeducation · Behavioral: Body functionality · Behavioral: Cognitive Dissonance

  • Experimental
    Arm 11

    Psychoeducation + self compassion + body function + cognitive dissonance

    Behavioral: Psychoeducation · Behavioral: Self-compassion · Behavioral: Body functionality · Behavioral: Cognitive Dissonance

Interventions

  • BehavioralPsychoeducation

    Briefly educates patients about the multifactorial origins of body size

  • BehavioralSelf-compassion

    Guides participants on a 5-minute self-compassion meditation targeted at internalized weight stigma and body acceptance

  • BehavioralBody functionality

    Presents patients with diverse body-functionality videos.

  • BehavioralCognitive Dissonance

    Prompts patients to complete a 2-minute cognitive-dissonance writing task

06

What researchers measure

Primary outcomes

  1. Weight Bias Internalization Scale - modified

    An 11-item validated measure of internalized weight stigma, modified for individuals across the weight spectrum

    Time frame: Immediately pre- and post-intervention

Secondary outcomes

  1. System Useability Scale

    A validated 10-item measure of perceived usability

    Time frame: Immediately post-intervention

  2. Qualitative Feedback Interview

    Explores the intervention's acceptability, usability, feasability, and areas for improvement.

    Time frame: Immediately post-intervention

Other outcomes

  1. Experienced Weight Bias Measure

    Assesses previous experiences of weight-based judgment or unfair treatment and is administered before the intervention.

    Time frame: Immediately pre-intervention

  2. Demographics and weight history

    Assesses previous experiences of weight-based judgment or unfair treatment.

    Time frame: Immediately pre-intervention

  3. Eating Disorder Examination Questionnaire

    A 28-item validated measure of eating-related attitudes and behaviors during the preceding 28 days

    Time frame: Immediately pre-intervention

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Dec 2027, 11 months later.

Of 22 interventional studies with no phase under Weight Prejudice, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 27. This study's planned 11 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 20, 2026
First posted
Nov 2, 2026
StartEst.
Jan 1, 2027
Primary completionEst.
Dec 31, 2027
CompletionEst.
Apr 1, 2028
Last update
Nov 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 2, 2026
Show all 1 update
  1. Nov 2, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07911462
Responsible party
Elizabeth.W.Lampe (Postdoctoral Fellow, Dartmouth-Hitchcock Medical Center) — Principal investigator
First posted
Nov 2, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
Dec 31, 2027 (estimated)
Completion
Apr 1, 2028 (estimated)
Last update
Nov 2, 2026

Study contacts

Elizabeth W Lampe, PhD
Contact
elizabeth.w.lampe@dartmouth.edu
(603) 646-7107 ext. 67107
Jessica Miller, B.A.
Contact
Jessica.Miller.PH@dartmouth.edu
Elizabeth Lampe, PhD
principal investigator · Dartmouth Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion